共 127 条
[21]
Libby P(2009)Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses Behav Res Methods 8 e60697-50
[22]
Thuno M(2013)Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy PLoS ONE 162 237-335
[23]
Macho B(2018)Changes in the burden of comorbidities in patients with COPD and Asthma-COPD Overlap according to the GOLD 2017 Recommendations Lung 12 3047-14
[24]
Eugen-Olsen J(2013)Chronic obstructive pulmonary disease and cardiovascular disease Transl Res 12 877-391
[25]
Blasi F(2017)High prevalence of COPD in atherosclerosis patients Int J Chron Obstruct Pulmon Dis 45 46-243
[26]
Carmeliet P(2017)Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis Internal Emerg Med 122 328-23
[27]
Gustafsson A(2017)Novel biomarkers for sepsis: a narrative review Eur J Internal Med 222 8-66
[28]
Ajeti V(2008)The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients Thromb Res 15 383-1302
[29]
Ljunggren L(2012)The urokinase system in the pathogenesis of atherosclerosis Atherosclerosis 216 237-785
[30]
Donadello K(2004)Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions Blood Coagul Fibrinolysis 45 18-1384